medigraphic.com

2017, Number 4

Next >>

Rev Clin Esc Med 2017; 7 (4)

Efectividad y seguridad de la quimioterapia de inducción en el tratamiento del Cáncer de colon en el Hospital San Juan de Dios durante los años 2010 y 2011

Ramos EA, Fernandez BC, Vargas MD, Cordero GE

Language: Spanish
References: 26
Page: 11-18
PDF size: 288.30 Kb.


ABSTRACT

Colorectal neoplasia is a malignant process involving several genetic and phenotypic alterations favoring the proliferation of malignant cells that end up generating a rigid lesion can be detected by techniques such as proctoscopy. This study analyzes the potential benefits of induction chemotherapy in patients diagnosed with this tumor. A retrospective analysis of 20 patients treated from 2010 to 2011, where the median follow- up was 69.5 months was performed. Induction chemotherapy was applied to 30% of the study population. Although no statistically significant differences in survival for patients receiving induction chemotherapy and that a "downstaging" positive no, it was shown by 30% of the study population and the absence of local and systemic recurrences in 80% from the patients.


REFERENCES

  1. Davis LE, Sun W, Medina PJ. Colorectal Cancer. En Pharmacotherapy: A Pathophysiologic Approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. (Eds). McGraw-Hill Companies Inc, New York, United States. 9ed, 2014.

  2. Holle LM, Clement JM, Davis LE. Colorectal Cancer. En Pharmacotherapy: A Pathophysiologic Approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. (Eds). McGraw-Hill Companies Inc, New York, United States. 10ed, 2017.

  3. Hanahan D, Weinberg R. Hallmarks of cancer: The next generation. Cell. 2014; 144: 646-674.

  4. NCCN: Clinical Practice Guidelines in Oncology. Rectal Cancer. 2016; 41- 187.

  5. Samalavicius N , Ambrazevicius M, Kilius A, Petrulis K. Transanal endoscopic microsurgery for early rectal cancer: single center experience. Wideochir Inne Tech Maloinwazyjne. 2014; 9 (4): 603-607

  6. Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D. Anal cancer treatment: Current status and future perspectives. World J Gastroenterol. 2015; 21(8): 2294-2302

  7. Hospital Universitario Reina Sofia. Subcomisión clínica de tumores digestivos: Protocolo cáncer colorectal. España: Universidad de Andalucía. 2013

  8. Glynne-Jones R, Grainger J, Harrison M, Ostler P, Makris A. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? British Journal of Cancer. 2006; 94: 363 – 371

  9. Glynne-Jones R, Ian Chau I. Neoadjuvant therapy before surgical treatment. EJC Supplements. 2013; 11: 45–59

  10. Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol 2002; 20:1744-1750.

  11. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEJM. 2004;351:1731–1740.

  12. Li J, Li L, Yang L et al. Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Oncotarget. 2016; 7(28): 44857-44870

  13. Rahbari NN, Elbers H, Askoxylakis V, et al. Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol 2013; 20:4169-4182.

  14. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004; 22:1785-1796.

  15. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide 2012. Disponible en: http://globocan.iarc.fr/old/burden.asp? selection_pop=44188&Textp= Costa+Rica&selection_cancer=5060 &Textc= Colorectum&pYear=3&type=0&window= 1&submit=%C2%A0Execute

  16. Registro Nacional de Tumores. Ministerio de Salud (2016). Situación epidemiológica del cáncer actualizado: Estadística de cáncer-Costa Rica. Disponible en: https://www.ministeriodesalud.go.cr/ind ex.php/vigilancia-de-lasalud/ estadisticas-y-bases-dedatos/ estadisticas/estadistica-de-cancerregistro- nacional-tumores/2722- situacion-epidemiologica-del-cancer/file

  17. Newcamb PA, carbine PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst. 1993; 85: 1580

  18. Extermann M, Boler I, reich RR et al. Predicting the risk of chemotherapy tox- icity in older patients: the Chemotherapy Risk Assessment scale for High Age Patients (CRASH) score. Cancer. 2012; 118: 3377

  19. Hurria A, Tagawa K, Mohile SG et al. Predicting chemotherapy toxicity in older adults with cancer-. A prospective multicenter study. J Clin Oncol 2011; 29: 3457

  20. Fernández-Martos C, Pericay C, Aparicio J et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer. J Clin Oncol. 2010;28(5):859-65.

  21. Mayer RJ. Lower Gastrointestinal Cancers. En Harrison's Principles of Internal Medicine. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J (Eds). McGraw-Hill Companies Inc, New York, United States. 19e, 2016.

  22. Bhatti A, Waheed A, Hafeez A et al. Can induction chemotherapy before concurrent chemoradiation impact circumferential resection margin positivity and survival in low rectal cancers? Asian Pac J Cancer Prev. 2015;16(7):2993-8.

  23. Chau I, Brown G, Cunningham D, et al. Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging– Defined Poor-Risk Rectal Cancer. J Clin Oncol. 2006,24:668-674.

  24. Nogué M, Salud A, Vicente P, Arriví A Roca JM Losa F Ponce J et al. Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging– Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study. Oncologist. 2011;16(5):614-20.

  25. Xynos E, Tekkis P, Gouvas N et al. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol. 2016; 29(2): 103–126.

  26. Haggstrom D, Cheung W. Approach to the long-term survivor of colorectal cancer.Wolters Kluer, UptoDate. 2015.




2020     |     www.medigraphic.com